Publications

 

  1. Chemerin Suppresses Breast Cancer Growth by Recruiting Immune Effector Cells Into the Tumor Microenvironment.

    Date: 2019
    PMID: 31139180
    Source: Front Immunol
    Authors: Pachynski RK, Wang P, Salazar N, Zheng Y, Nease L, Rosalez J, Leong WI, Virdi G, Rennier K, Shin WJ, Nguyen V, Butcher EC, Zabel BA
    Article ID(s): pubmed:31139180, pmc:PMC6518384, pmcid:pmc-id: PMC6518384;, doi:10.3389/fimmu.2019.00983
    Read More
  2. A phospholipase D2 inhibitor, CAY10594, ameliorates acetaminophen-induced acute liver injury by regulating the phosphorylated-GSK-3β/JNK axis.

    Date: 2019 May 10
    PMID: 31076618
    Source: Sci Rep
    Authors: Lee SK, Bae GH, Kim YS, Kim HS, Lee M, Ghim J, Zabel BA, Ryu SH, Bae YS
    Article ID(s): pubmed:31076618, pmc:PMC6510900, pmcid:pmc-id: PMC6510900;, doi:10.1038/s41598-019-43673-x, pii:10.1038/s41598-019-43673-x
    Read More
  3. Novel CMKLR1 Inhibitors for Application in Demyelinating Disease.

    Date: 2019 May 9
    PMID: 31073181
    Source: Sci Rep
    Authors: Kumar V, LaJevic M, Pandrala M, Jacobo SA, Malhotra SV, Zabel BA
    Article ID(s): pubmed:31073181, pmc:PMC6509344, pmcid:pmc-id: PMC6509344;, doi:10.1038/s41598-019-43428-8, pii:10.1038/s41598-019-43428-8
    Read More
  4. Support of Tumor Endothelial Cells by Chemokine Receptors.

    Date: 2019
    PMID: 30800123
    Source: Front Immunol
    Authors: Salazar N, Zabel BA
    Article ID(s): pubmed:30800123, pmc:PMC6375834, pmcid:pmc-id: PMC6375834;, doi:10.3389/fimmu.2019.00147
    Read More
  5. DGAT1 inhibits retinol-dependent regulatory T cell formation and mediates autoimmune encephalomyelitis.

    Date: 2019 Feb 19
    PMID: 30718413
    Source: Proc Natl Acad Sci U S A
    Authors: Graham KL, Werner BJ, Moyer KM, Patton AK, Krois CR, Yoo HS, Tverskoy M, LaJevic M, Napoli JL, Sobel RA, Zabel BA, Butcher EC
    Article ID(s): pubmed:30718413, pmc:PMC6386656, pmcid:pmc-id: PMC6386656;, doi:10.1073/pnas.1817669116, pii:1817669116
    Read More
  6. Mechanisms and Functions of Chemerin in Cancer: Potential Roles in Therapeutic Intervention.

    Date: 2018
    PMID: 30555465
    Source: Front Immunol
    Authors: Shin WJ, Zabel BA, Pachynski RK
    Article ID(s): pubmed:30555465, pmc:PMC6283908, pmcid:pmc-id: PMC6283908;, doi:10.3389/fimmu.2018.02772
    Read More
  7. The antimicrobial activity of chemerin-derived peptide p4 requires oxidative conditions.

    Date: 2019 Jan 25
    PMID: 30504221
    Source: J Biol Chem
    Authors: Godlewska U, Bilska B, Zegar A, Brzoza P, Borek A, Murzyn K, Bochenska O, Morytko A, Kuleta P, Kozik A, Pyza E, Osyczka A, Zabel BA, Cichy J
    Article ID(s): pubmed:30504221, pmc:PMC6349111, pmcid:pmc-id: PMC6349111;, doi:10.1074/jbc.RA118.005495, pii:S0021-9258(20)38864-5
    Read More
  8. The impact of chemerin or chemokine-like receptor 1 loss on the mouse gut microbiome.

    Date: 2018
    PMID: 30225164
    Source: PeerJ
    Authors: Dranse HJ, Zheng A, Comeau AM, Langille MGI, Zabel BA, Sinal CJ
    Article ID(s): pubmed:30225164, pmc:PMC6139019, pmcid:pmc-id: PMC6139019;, doi:10.7717/peerj.5494, pii:5494
    Read More
  9. A Chimeric Antibody against ACKR3/CXCR7 in Combination with TMZ Activates Immune Responses and Extends Survival in Mouse GBM Models.

    Date: 2018 May 2
    PMID: 29606504
    Source: Mol Ther
    Authors: Salazar N, Carlson JC, Huang K, Zheng Y, Oderup C, Gross J, Jang AD, Burke TM, Lewén S, Scholz A, Huang S, Nease L, Kosek J, Mittelbronn M, Butcher EC, Tu H, Zabel BA
    Article ID(s): pubmed:29606504, pmc:PMC5993942, pmcid:pmc-id: PMC5993942;, doi:10.1016/j.ymthe.2018.02.030, pii:S1525-0016(18)30106-0
    Read More
  10. A Mucosal and Cutaneous Chemokine Ligand for the Lymphocyte Chemoattractant Receptor GPR15.

    Date: 2017
    PMID: 28936214
    Source: Front Immunol
    Authors: Ocón B, Pan J, Dinh TT, Chen W, Ballet R, Bscheider M, Habtezion A, Tu H, Zabel BA, Butcher EC
    Article ID(s): pubmed:28936214, pmc:PMC5594226, pmcid:pmc-id: PMC5594226;, doi:10.3389/fimmu.2017.01111
    Read More